(Q38957367)

8 September 2017

title

Oestetrol stimulates proliferation and oestrogen receptor expression in breast cancer cell lines: comparison of four oestrogens (English)

1 reference

8 September 2017

1 reference

Shunyu Liu

1

1 reference

8 September 2017

Xiangyan Ruan

2

1 reference

8 September 2017

Silke Schultz

3

1 reference

8 September 2017

Hans Neubauer

4

1 reference

8 September 2017

Tanja Fehm

5

1 reference

8 September 2017

Harald Seeger

6

1 reference

8 September 2017

Alfred O Mueck

7

1 reference

8 September 2017

publication date

12 September 2014

1 reference

The European Journal of Contraception Reproductive Health Care

8 September 2017

published in

1 reference

8 September 2017

volume

20

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

29-35

1 reference

Premature ovarian failure: a growing concern

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Comparison of the proliferative effects of ethinylestradiol on human breast cancer cells in an intermittent and a continuous dosing regime

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Proliferative effects of estradiol- or ethinylestradiol-progestogen combinations on human breast cancer cells in an intermitted and a long-term regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Possible role of PGRMC1 in breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Estetrol review: profile and potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Estetrol, a pregnancy-specific human steroid, prevents and suppresses mammary tumor growth in a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Clinical applications for estetrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Progesterone receptor membrane component 1: an integrative review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13625187.2014.951997

10.3109/13625187.2014.951997

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference